Asian Journal of Biomedical and Pharmaceutical Sciences

Reach Us +1 (202) 780-3397

Commentary - Asian Journal of Biomedical and Pharmaceutical Sciences (2024) Volume 14, Issue 106

The role of pharmacogenomics in advancing biomedical science and personalized medicine.

Van Audisio *

Department of Biomedical, University of Bordeaux, France

*Corresponding Author:
Van Audisio
Department of Biomedical, University of Bordeaux, France
E-mail: Van@Audisio.fr

Received: 01-July-2024, Manuscript No. AABPS-24-143250; Editor assigned: 02-July-2024, PreQC No. AABPS-24-143250 (PQ); Reviewed: 15-July-2024, QC No. AABPS-24-143250; Revised: 19-July-2024, Manuscript No. AABPS-24-143250(R); Published: 26-July-2024, DOI: 10.35841/aabps-14.106.243

Citation: : Audisio V. The role of pharmacogenomics in advancing biomedical science and personalized medicine. Asian J Biomed Pharm Sci. 2024;14(106):243

Introduction

Pharmacogenomics, a field at the intersection of pharmacology and genomics, explores how an individual's genetic makeup influences their response to drugs. This branch of biomedical science aims to optimize drug therapy, ensuring maximum efficacy and minimal adverse effects by tailoring treatments to each patient's genetic profile [1]. As healthcare moves towards personalized medicine, pharmacogenomics plays a crucial role in understanding the genetic factors that affect drug metabolism and action. This article delves into the significance of pharmacogenomics in biomedical science, its applications in personalized medicine, and the challenges and future prospects of this evolving field [2] [1, 2].

Understanding Pharmacogenomics Pharmacogenomics examines the relationship between genetic variations and drug responses. Key concepts include. Genetic Polymorphisms Variations in DNA sequences that can affect drug metabolism, efficacy, and toxicity [3]. Cytochrome P450 Enzymes A family of enzymes critical for drug metabolism, where genetic variations can significantly influence drug processing in the body. Drug Targets Genes encoding proteins that drugs interact with, where variations can alter drug effectiveness and safety [4]. Applications in Personalized Medicine Pharmacogenomics is instrumental in advancing personalized medicine by Optimizing Drug Therapy Tailoring drug choice and dosage based on genetic profiles to improve therapeutic outcomes and reduce adverse effects [5]. Reducing Adverse Drug Reactions (ADRs) Identifying genetic markers that predict the risk of ADRs, enhancing patient safety [6]. [3-6].

Improving Drug Development Informing the design of clinical trials by considering genetic diversity, leading to more effective and safer drugs. Case Studies in Pharmacogenomics Several real-world examples illustrate the impact of pharmacogenomics Warfarin Genetic variations in the CYP2C9 and VKORC1 genes affect warfarin metabolism and response, guiding personalized dosing to prevent bleeding complications [7]. Oncology Genetic profiling of tumors helps identify mutations that predict responses to targeted therapies, such as HER2 in breast cancer or EGFR in lung cancer. Psychiatry Genetic variations in enzymes like CYP2D6 influence the metabolism of antidepressants and antipsychotics, aiding in personalized treatment plans [8]. [7, 8].

Challenges in Pharmacogenomics Despite its promise, pharmacogenomics face several challenges. Complexity of Genetic Interactions The interaction between multiple genes and environmental factors complicates the prediction of drug responses. Ethical and Privacy Concerns Genetic testing raises issues of confidentiality, potential discrimination, and informed consent. Integration into Clinical Practice Incorporating pharmacogenomic data into routine clinical care requires education, infrastructure, and standardized guidelines [9].

Future Prospects the future of pharmacogenomics is bright, with ongoing research and technological advancements driving progress Next-Generation Sequencing (NGS) High-throughput sequencing technologies enable comprehensive genetic profiling, accelerating pharmacogenomic discoveries. Artificial Intelligence (AI) AI and machine learning algorithms can analyze vast genetic and clinical data sets, uncovering complex patterns and improving predictive accuracy.Global Collaboration International consortia and databases, like the 1000 Genomes Project, enhance understanding of genetic diversity and its implications for drug therapy [10].

Conclusion

Pharmacogenomics represents a paradigm shift in biomedical science and personalized medicine, offering the potential to revolutionize drug therapy by tailoring treatments to an individual's genetic makeup. By optimizing drug efficacy and safety, pharmacogenomics not only enhances patient outcomes but also contributes to the development of more effective therapies. Despite the challenges, ongoing research and technological advancements promise to overcome these hurdles, paving the way for widespread integration of pharmacogenomics into clinical practice. As we continue to unravel the complexities of the human genome, the role of pharmacogenomics in shaping the future of healthcare becomes increasingly vital.

References

  1. Singh DB. The impact of pharmacogenomics in personalized medicine. Adv Biochem Eng Biotechnol. 2020:369-94.

    2. Indexed at, Google Scholar, Cross Ref

  2. Balogun, O.D., Ayo-Farai, O., Ogundairo, O., et al. The role of pharmacists in personalised medicine: A review of integrating pharmacogenomics into clinical practice. Internat Med Sci Res J. 4(1):19-36.

    3. Indexed at, Google Scholar, Cross Ref

  3. Cecchin E, Stocco G. Pharmacogenomics and personalized medicine. Genes. 2020;11(6):679.

    4. Google Scholar

  4. Griñán-Ferré C, Bellver-Sanchis A, Guerrero A, et al. Advancing personalized medicine in neurodegenerative diseases: The role of epigenetics and pharmacoepigenomics in pharmacotherapy. Pharmacol Res. 2024;205:107247.

    5. Indexed at, Google Scholar, Cross Ref

  5. Micaglio E, Locati ET, Monasky MM, et al. Role of pharmacogenetics in adverse drug reactions: An update towards personalized medicine. Front Pharmacol. 2021;12:651720.

    6. Indexed at, Google Scholar, Cross Ref

  6. Hoffman JM, Flynn AJ, Juskewitch JE, et al. Biomedical data science and informatics challenges to implementing pharmacogenomics with electronic health records. Annu. Rev. Biomed. Data Sci. 2020;3(1):289-314.

    7. Indexed at, Google Scholar, Cross Ref

  7. Chenoweth MJ, Giacomini KM, Pirmohamed M, et al. Global pharmacogenomics within precision medicine: Challenges and opportunities. Clin Pharmacol Ther. 2020;107(1):57-61.

    8. Indexed at, Google Scholar, Cross Ref

  8. Primorac D, Bach-Rojecky L, Va?unec D, et al. Pharmacogenomics at the center of precision medicine: Challenges and perspective in an era of Big Data. Pharmacogenomics. 2020;21(2):141-56.

    9. Indexed at, Google Scholar, Cross Ref

  9. Sadee W, Wang D, Hartmann K, et al. Pharmacogenomics: driving personalized medicine. Pharmacol Rev. 2023;75(4):789-814.

    10. Indexed at, Google Scholar, Cross Ref

  10. Hassan R, Allali I, Agamah FE, et al. Drug response in association with pharmacogenomics and pharmacomicrobiomics: Towards a better personalized medicine. Brief Bioinform. 2021;22(4):292.

    11. Indexed at, Google Scholar, Cross Ref

     

Get the App